Kim L. Clar
Otfried Müller Str. 10
Tuebingen, BW 72076, Germany
Tuebingen, BW 72076, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Phase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiency.
Journal: Nature communications
Published: June 14, 2023
Controversial Role of the Immune Checkpoint OX40L Expression on Platelets in Breast Cancer Progression.
Journal: Frontiers in oncology
Published: April 11, 2022
Bispecific NKG2D-CD3 and NKG2D-CD16 Fusion Proteins as Novel Treatment Option in Advanced Soft Tissue Sarcomas.
Journal: Frontiers in immunology
Published: January 13, 2021
Platelet-expressed immune checkpoint regulator GITRL in breast cancer.
Journal: Cancer immunology, immunotherapy : CII
Published: June 30, 2020
Cancer Cells Invade Confined Microchannels via a Self-Directed Mesenchymal-to-Amoeboid Transition.
Journal: Nano letters
Published: February 19, 2019
Inhibition of NK Reactivity Against Solid Tumors by Platelet-Derived RANKL.
Journal: Cancers
Published: January 29, 2019
The novel deubiquitinase inhibitor b-AP15 induces direct and NK cell-mediated antitumor effects in human mantle cell lymphoma.
Journal: Cancer immunology, immunotherapy : CII
Published: August 23, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026